Third Quarter Net Revenue of
Reaches Record Dollar and Volume Share of the Shell Egg Category
Updates Fiscal Year 2026 Net Revenue Outlook to around
Withdraws Previously Issued Fiscal 2030 Financial Targets
Financial highlights for the third quarter ended
- Net Revenue of
$182.2 million , a decrease of 8.4% year over year and an increase of 9.7% sequentially from the second quarter of fiscal 2026 - Gross Margin of 23.1%, compared to 37.7%
- Net Loss of
$6.5 million , compared to Net Income of$16.4 million - Net Loss per Diluted Share of
$0.15 , compared to Net Income per Diluted Share of$0.36 - Adjusted EBITDA of
$1.5 million , compared to$27.4 million in the prior-year quarter but improved$28.1 million sequentially from the second quarter of fiscal 20261
“Q3 represented a meaningful sequential improvement from Q2, consistent with our previously communicated expectation that Q2 would represent the trough in our financial performance. Net revenue and Adjusted EBITDA both improved sequentially, distribution expanded, we reached record dollar and volume share of the shell egg category, and we made progress reducing excess supply and lowering our cost structure,” said
“At the same time, our performance this year has given us a clearer understanding of the factors affecting our growth as the egg category has normalized following several years of disruption from avian influenza. We achieved the distribution gains we expected, although some of that distribution came on shelf later than planned, and we are taking a more conservative view of its near-term velocity contribution. We are focused on building velocity across our expanded distribution base, adding distribution where it makes sense, bringing new households to the Vital Farms brand, and maintaining discipline across supply and costs. We remain confident in Vital Farms’ long-term opportunity, and we are focused on demonstrating sustained progress through more consistent growth and improved profitability over time.”
1 Adjusted EBITDA is a non-GAAP financial measure defined in the section titled “Non-GAAP Financial Measures” below and is reconciled to net (loss) income, its closest comparable GAAP measure, at the end of this release. |
For the 13 Weeks Ended
Net revenue decreased 8.4% to
Gross profit was
Loss from operations was
Net loss was
Net loss per diluted share was
Adjusted EBITDA was
Adjusted EBITDA excludes certain non-cash and other items. Adjusted EBITDA is a non-GAAP financial measure defined in the section titled “Non-GAAP Financial Measures” below and is reconciled to net (loss) income, its closest comparable GAAP measure, at the end of this release.
Balance Sheet and Cash Flow Highlights
Cash and cash equivalents were
Capital expenditures totaled
Fiscal 2026 Outlook
“We continue to expect sequential improvement in Q4 compared with Q3, supported by lower anticipated breaker and supply-management costs, the benefit of recent distribution gains and structural cost actions we have taken across the business,” said
For fiscal year 2026, we expect:
- Net revenue of around
$730 million , compared to prior outlook of$775 million to$800 million . - Adjusted EBITDA loss of around
$(15) million , compared to prior outlook of a gain between$0 and$10 million . - Capital expenditures in the range of
$70 million to$75 million , reaffirmed from our prior outlook.
Vital Farms’ guidance assumes that there are no further material disruptions to the supply chain or its customers or consumers, including any material changes to the current macroeconomic environment.
Long-Term Targets
As
Conference Call and Webcast Details
In addition,
About
Forward-Looking Statements
This press release and the earnings call referencing this press release contain “forward-looking” statements, as that term is defined under the federal securities laws, including but not limited to statements regarding Vital Farms’ long-term opportunity, business strategy and commercial and operational priorities, the impact and expected benefits of changes in Vital Farms’ cost structure and capital expenditures, and Vital Farms’ future financial performance, including management’s outlook for fiscal year 2026. These forward-looking statements are based on Vital Farms’ current assumptions, expectations, and beliefs and are subject to substantial risks, uncertainties, assumptions, and changes in circumstances that may cause Vital Farms’ actual results, performance, or achievements to differ materially from those expressed or implied in any forward-looking statement.
The risks and uncertainties referred to above include, but are not limited to: Vital Farms’ expectations regarding its revenue, expenses, and other operating results; Vital Farms’ ability to attract new consumers and customers, to successfully retain existing consumers and customers, to attract and retain its suppliers, distributors, and co-manufacturers, and to maintain its relationships with the farmers in its network and further expand its farm network, and plans for operation of accelerator farms and the impact of its decision to pause development of future accelerator farms; Vital Farms’ ability to sustain or increase its profitability; Vital Farms’ expectations regarding its future growth in the foodservice channel; Vital Farms’ ability to procure sufficient high-quality eggs and other raw materials; Vital Farms’ ability to effectively manage its supply of eggs and the impact of its current and planned supply control initiatives; real or perceived quality or food safety issues with Vital Farms’ products or other issues that adversely affect Vital Farms’ brand and reputation; Vital Farms’ ability to manage changes in the tastes and preferences of consumers; the financial condition of, and Vital Farms’ relationships with, its farmers, pullet vendors, suppliers, co-manufacturers, distributors, retailers, and foodservice customers, as well as the health of the foodservice industry generally; the effects of outbreaks of agricultural diseases, including avian influenza and egg drop syndrome, the perception that outbreaks may occur or regulatory or market responses to such outbreaks generally; the ability of
These risks and uncertainties are more fully described in Vital Farms’ filings with the Securities and Exchange Commission (SEC), including in the sections entitled “Risk Factors” in its Quarterly Report on Form 10-Q for the fiscal quarter ended
CONDENSED CONSOLIDATED STATEMENTS OF INCOME | ||||||||||||||||
(Amounts in thousands, except share amounts) | ||||||||||||||||
(Unaudited) | ||||||||||||||||
|
| 13-Weeks Ended |
|
| 39-Weeks Ended |
| ||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
| ||||
Net revenue |
| $ | 182,164 |
|
| $ | 198,936 |
|
| $ | 535,348 |
|
| $ | 545,892 |
|
Cost of goods sold |
|
| 140,024 |
|
|
| 123,974 |
|
|
| 429,268 |
|
|
| 336,635 |
|
Gross profit |
|
| 42,140 |
|
|
| 74,962 |
|
|
| 106,080 |
|
|
| 209,257 |
|
Operating expenses: |
|
|
|
|
|
|
|
|
|
|
|
| ||||
Selling, general and administrative |
|
| 38,136 |
|
|
| 44,394 |
|
|
| 122,876 |
|
|
| 115,290 |
|
Shipping and distribution |
|
| 11,685 |
|
|
| 9,169 |
|
|
| 33,364 |
|
|
| 27,004 |
|
Total operating expenses |
|
| 49,821 |
|
|
| 53,563 |
|
|
| 156,240 |
|
|
| 142,294 |
|
(Loss) income from operations |
|
| (7,681 | ) |
|
| 21,399 |
|
|
| (50,160 | ) |
|
| 66,963 |
|
Other income (expense), net: |
|
|
|
|
|
|
|
|
|
|
|
| ||||
Interest expense |
|
| (2,930 | ) |
|
| (213 | ) |
|
| (3,541 | ) |
|
| (666 | ) |
Interest income |
|
| 330 |
|
|
| 1,270 |
|
|
| 1,330 |
|
|
| 3,814 |
|
Other income (expense), net |
|
| 1,046 |
|
|
| (487 | ) |
|
| 487 |
|
|
| (1,268 | ) |
Total other (expense) income, net |
|
| (1,554 | ) |
|
| 570 |
|
|
| (1,724 | ) |
|
| 1,880 |
|
Net (loss) income before income taxes |
|
| (9,235 | ) |
|
| 21,969 |
|
|
| (51,884 | ) |
|
| 68,843 |
|
Income tax (benefit) provision |
|
| (2,775 | ) |
|
| 5,550 |
|
|
| (12,837 | ) |
|
| 18,885 |
|
Net (loss) income |
| $ | (6,460 | ) |
| $ | 16,419 |
|
| $ | (39,047 | ) |
| $ | 49,958 |
|
Net (loss) income per share: |
|
|
|
|
|
|
|
|
|
|
|
| ||||
Basic: |
| $ | (0.15 | ) |
| $ | 0.37 |
|
| $ | (0.91 | ) |
| $ | 1.12 |
|
Diluted: |
| $ | (0.15 | ) |
| $ | 0.36 |
|
| $ | (0.91 | ) |
| $ | 1.09 |
|
Weighted average common shares outstanding: |
|
|
|
|
|
|
|
|
|
|
|
| ||||
Basic: |
|
| 42,931,849 |
|
|
| 44,721,206 |
|
|
| 42,730,366 |
|
|
| 44,521,146 |
|
Diluted: |
|
| 42,931,849 |
|
|
| 46,205,737 |
|
|
| 42,730,366 |
|
|
| 45,965,987 |
|
CONDENSED CONSOLIDATED BALANCE SHEETS | ||||||||
(Amounts in thousands, except share amounts) | ||||||||
(Unaudited) | ||||||||
|
|
|
|
|
|
| ||
|
| (Unaudited) |
|
|
|
| ||
Assets |
|
|
|
|
|
| ||
Current assets: |
|
|
|
|
|
| ||
Cash and cash equivalents |
| $ | 83,952 |
|
| $ | 48,831 |
|
Investment securities, available-for-sale |
|
| — |
|
|
| 64,520 |
|
Accounts receivable, net of allowance for credit losses of |
|
| 60,615 |
|
|
| 67,849 |
|
Inventories |
|
| 50,253 |
|
|
| 66,495 |
|
Prepaid expenses and other current assets, net of allowance for credit losses of |
|
| 15,347 |
|
|
| 11,304 |
|
Income taxes receivable |
|
| 1,725 |
|
|
| 1,410 |
|
Assets held for sale |
|
| 2,141 |
|
|
| 2,141 |
|
Total current assets |
|
| 214,033 |
|
|
| 262,550 |
|
Property, plant and equipment, net |
|
| 195,676 |
|
|
| 160,601 |
|
Operating lease right-of-use assets |
|
| 132,617 |
|
|
| 80,390 |
|
|
| 27,825 |
|
|
| 15,197 |
| |
Total assets |
| $ | 570,151 |
|
| $ | 518,738 |
|
Liabilities and Stockholders’ Equity |
|
|
|
|
|
| ||
Current liabilities: |
|
|
|
|
|
| ||
Accounts payable |
| $ | 47,972 |
|
| $ | 55,141 |
|
Accrued liabilities |
|
| 52,339 |
|
|
| 54,826 |
|
Operating lease liabilities, current |
|
| 29,320 |
|
|
| 4,673 |
|
Finance lease liabilities, current |
|
| 6,005 |
|
|
| 5,670 |
|
Current portion of long-term debt |
|
| 1,250 |
|
|
| — |
|
Income taxes payable |
|
| 44 |
|
|
| 1,268 |
|
Total current liabilities |
|
| 136,930 |
|
|
| 121,578 |
|
Long-term debt, less current portion |
|
| 116,385 |
|
|
| — |
|
Operating lease liabilities, non-current |
|
| 35,457 |
|
|
| 38,050 |
|
Finance lease liabilities, non-current |
|
| 556 |
|
|
| 5,098 |
|
Other liabilities |
|
| 512 |
|
|
| 2,752 |
|
Total liabilities |
| $ | 289,840 |
|
| $ | 167,478 |
|
Commitments and contingencies |
|
|
|
|
|
| ||
Stockholders’ equity: |
|
|
|
|
|
| ||
Preferred stock, |
|
| — |
|
|
| — |
|
Common stock, |
|
| 4 |
|
|
| 4 |
|
Additional paid-in capital |
|
| 169,951 |
|
|
| 201,820 |
|
Retained earnings |
|
| 110,348 |
|
|
| 149,395 |
|
Accumulated other comprehensive income |
|
| 8 |
|
|
| 41 |
|
Total stockholders’ equity |
| $ | 280,311 |
|
| $ | 351,260 |
|
Total liabilities and stockholders’ equity |
| $ | 570,151 |
|
| $ | 518,738 |
|
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS | ||||||||
(Amounts in thousands) | ||||||||
(Unaudited) | ||||||||
|
| 39-Weeks Ended |
| |||||
|
|
|
|
|
|
| ||
Cash flows from operating activities: |
|
|
|
|
|
| ||
Net (loss) income |
| $ | (39,047 | ) |
| $ | 49,958 |
|
Adjustments to reconcile net (loss) income to net cash (used in) provided by operating activities: |
|
|
|
|
|
| ||
Depreciation and amortization |
|
| 11,914 |
|
|
| 9,963 |
|
Reduction in the carrying amount of right-of-use assets |
|
| 13,483 |
|
|
| 6,018 |
|
Stock-based compensation expense |
|
| 4,500 |
|
|
| 9,126 |
|
Amortization of capitalized cloud computing arrangement costs |
|
| 2,090 |
|
|
| — |
|
Amortization and accretion of available-for-sale securities |
|
| (526 | ) |
|
| (720 | ) |
Amortization of debt issuance costs |
|
| 699 |
|
|
| 64 |
|
Uncertain tax positions |
|
| (1,160 | ) |
|
| 1,580 |
|
Deferred taxes |
|
| (13,250 | ) |
|
| 28 |
|
Net realized (gains) losses on derivative instruments |
|
| (455 | ) |
|
| 1,325 |
|
Increase in inventory provision |
|
| 4,056 |
|
|
| 2,488 |
|
Other |
|
| 3,541 |
|
|
| 1,390 |
|
Net change in operating assets and liabilities |
|
| (40,285 | ) |
|
| (53,285 | ) |
Net cash (used in) provided by operating activities |
| $ | (54,440 | ) |
| $ | 27,935 |
|
Cash flows from investing activities: |
|
|
|
|
|
| ||
Purchases of property, plant and equipment |
|
| (51,726 | ) |
|
| (44,024 | ) |
Purchases of available-for-sale securities |
|
| - |
|
|
| (70,431 | ) |
Proceeds from the sale of available-for-sale securities |
|
| 43,002 |
|
|
| 404 |
|
Maturities of available-for-sale securities |
|
| 22,000 |
|
|
| 29,240 |
|
Purchases and settlements of derivative instruments |
|
| (611 | ) |
|
| (551 | ) |
Proceeds from the sale of property, plant and equipment |
|
| 126 |
|
|
| 1,026 |
|
Net cash provided by (used in) investing activities |
| $ | 12,791 |
|
| $ | (84,336 | ) |
Cash flows from financing activities: |
|
|
|
|
|
| ||
Proceeds from Silver Point Term Loan |
|
| 120,617 |
|
|
| — |
|
Proceeds from draw on JPMorgan Credit Facility |
|
| 30,000 |
|
|
| — |
|
Proceeds from issuance of common stock under employee stock purchase plan |
|
| 404 |
|
|
| 379 |
|
Proceeds from exercise of stock options |
|
| 9 |
|
|
| 5,512 |
|
Repurchases of common stock |
|
| (35,001 | ) |
|
| — |
|
Payment on JPMorgan Credit Facility |
|
| (30,000 | ) |
|
| — |
|
Principal payments under finance lease obligations |
|
| (4,346 | ) |
|
| (3,200 | ) |
Payments of debt issuance costs |
|
| (3,281 | ) |
|
| — |
|
Payment of tax withholding obligation on vested restricted stock unit shares |
|
| (1,632 | ) |
|
| (3,095 | ) |
Net cash provided by (used in) financing activities |
| $ | 76,770 |
|
| $ | (404 | ) |
Net increase (decrease) in cash and cash equivalents |
|
| 35,121 |
|
|
| (56,805 | ) |
Cash and cash equivalents at beginning of the period |
|
| 48,831 |
|
|
| 150,601 |
|
Cash and cash equivalents at end of the period |
| $ | 83,952 |
|
| $ | 93,796 |
|
Supplemental disclosure of cash flow information: |
|
|
|
|
|
| ||
Cash paid for interest |
| $ | 863 |
|
| $ | 601 |
|
Cash paid for income taxes, net of amounts refunded |
|
| 2,031 |
|
|
| 17,230 |
|
Supplemental disclosure of non-cash investing and financing activities: |
|
|
|
|
|
| ||
Purchases of property, plant and equipment included in accounts payable and accrued liabilities |
| $ | 5,460 |
|
| $ | 4,671 |
|
Non-GAAP Financial Measures
We report our financial results in accordance with GAAP. However, management believes that non-GAAP financial measures, including Adjusted EBITDA, Adjusted EBITDA Margin, Adjusted Net (Loss) Income and Adjusted Net (Loss) Income per Share, provide investors with additional useful information in evaluating our performance.
Adjusted EBITDA, Adjusted EBITDA Margin, Adjusted Net (Loss) Income and Adjusted Net (Loss) Income per Share are financial measures that are not required by or presented in accordance with GAAP. We believe that these non-GAAP financial measures, when taken together with our financial results presented in accordance with GAAP, provide meaningful supplemental information regarding our operating performance and facilitate internal comparisons of our historical operating performance on a more consistent basis by excluding certain items that may not be indicative of our business, results of operations or outlook.
In particular, we believe that the use of Adjusted EBITDA and Adjusted EBITDA Margin is helpful to our investors as they are measures used by management in assessing the health of our business, determining incentive compensation and evaluating our operating performance, as well as for internal planning and forecasting purposes. We calculate Adjusted EBITDA as net (loss) income, adjusted to exclude: (1) depreciation and amortization; (2) stock-based compensation expense; (3) (benefit) or provision for income taxes as applicable; (4) interest expense; (5) interest income; (6) amortization of cloud computing arrangements; (7) restructuring and severance costs; and (8) costs related to our exit of our butter business. We calculate Adjusted EBITDA Margin as Adjusted EBITDA divided by net revenue.
We believe that the use of Adjusted Net (Loss) Income and Adjusted Net (Loss) Income per Share is helpful to our investors, as these measures are used by management in assessing the ongoing operating performance and underlying earnings potential of our business, as well as for internal planning and forecasting purposes. Unlike Adjusted EBITDA, these measures retain the impact of depreciation, amortization, interest, taxes, and non-cash charges.
We calculate Adjusted Net (Loss) Income as net (loss) income, adjusted to exclude: (1) restructuring and severance costs; and (2) costs related to our exit of our butter business. We calculate Adjusted Net (Loss) Income per Share as Adjusted Net (Loss) Income divided by weighted average common shares outstanding, basic and diluted.
These non-GAAP financial measures are presented for supplemental informational purposes only, have limitations as analytical tools and should not be considered in isolation or as a substitute for financial information presented in accordance with GAAP.
Some of the limitations of Adjusted EBITDA and Adjusted EBITDA Margin include that (1) they do not properly reflect capital commitments to be paid in the future, (2) although depreciation and amortization are non-cash charges, the underlying assets may need to be replaced and Adjusted EBITDA and Adjusted EBITDA Margin do not reflect these capital expenditures, (3) they do not consider the impact of stock-based compensation expense, (4) they do not reflect other non-operating expenses, including interest expense; (5) they do not reflect tax payments that may represent a reduction in cash available to us; and (6) they do not reflect certain non-recurring items such as restructuring, severance and the wind-down of our butter business.
In addition, some of the limitations of Adjusted EBITDA, Adjusted EBITDA Margin, Adjusted Net (Loss) Income and Adjusted Net (Loss) Income per Share include that (1) certain excluded items represent actual cash expenditures that reduced our liquidity; and (2) they involve management’s judgment as to what items to exclude.
Our use of non-GAAP financial measures may not be comparable to similarly titled measures of other companies because they may not calculate such non-GAAP financial measures in the same manner, limiting the usefulness as comparative measures. Because of these limitations, when evaluating our performance, you should consider non-GAAP financial measures alongside other financial measures, including our net (loss) income, net (loss) income margin, net (loss) income per share and other results stated in accordance with GAAP.
ADJUSTED EBITDA RECONCILIATION | ||||||||||||||||
(Amounts in thousands) | ||||||||||||||||
(Unaudited) | ||||||||||||||||
|
| 13-Weeks Ended |
|
| 39-Weeks Ended |
| ||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
| ||||
|
| (in thousands) |
|
| (in thousands) |
| ||||||||||
Net (loss) income |
| $ | (6,460 | ) |
| $ | 16,419 |
|
| $ | (39,047 | ) |
| $ | 49,958 |
|
Depreciation and amortization1 |
|
| 4,317 |
|
|
| 3,236 |
|
|
| 11,914 |
|
|
| 9,963 |
|
Stock-based compensation (benefit) expense |
|
| 3,122 |
|
|
| 3,239 |
|
|
| 4,500 |
|
|
| 9,126 |
|
Income tax (benefit) provision |
|
| (2,775 | ) |
|
| 5,550 |
|
|
| (12,837 | ) |
|
| 18,885 |
|
Interest expense |
|
| 2,930 |
|
|
| 213 |
|
|
| 3,541 |
|
|
| 666 |
|
Interest income |
|
| (330 | ) |
|
| (1,270 | ) |
|
| (1,330 | ) |
|
| (3,814 | ) |
Amortization of cloud computing arrangements |
|
| 693 |
|
|
| — |
|
|
| 2,090 |
|
|
| — |
|
Restructuring and severance costs |
|
| — |
|
|
| — |
|
|
| 3,312 |
|
|
| — |
|
Costs related to our exit of butter products |
|
| — |
|
|
| — |
|
|
| 7,764 |
|
|
| — |
|
Adjusted EBITDA |
| $ | 1,497 |
|
| $ | 27,387 |
|
| $ | (20,093 | ) |
| $ | 84,784 |
|
|
|
|
|
|
|
|
|
|
|
|
|
| ||||
Net revenue |
| $ | 182,164 |
|
| $ | 198,936 |
|
| $ | 535,348 |
|
| $ | 545,892 |
|
Net (loss) income margin2 |
|
| (3.5 | )% |
|
| 8.3 | % |
|
| (7.3 | )% |
|
| 9.2 | % |
Adjusted EBITDA margin3 |
|
| 0.8 | % |
|
| 13.8 | % |
|
| (3.8 | )% |
|
| 15.5 | % |
(1) | Amount also includes finance lease amortization. | |
(2) | Net (loss) income margin is calculated by dividing net (loss) income by net revenue | |
(3) | Adjusted EBITDA margin is calculated by dividing Adjusted EBITDA by net revenue |
ADJUSTED NET (LOSS) INCOME RECONCILIATION | ||||||||||||||||
(Amounts in thousands) | ||||||||||||||||
(Unaudited) | ||||||||||||||||
|
| 13-Weeks Ended |
|
| 39-Weeks Ended |
| ||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
| ||||
|
| (in thousands) |
|
| (in thousands) |
| ||||||||||
Net (loss) income |
| $ | (6,460 | ) |
| $ | 16,419 |
|
| $ | (39,047 | ) |
| $ | 49,958 |
|
Restructuring and severance costs |
|
| — |
|
|
| — |
|
|
| 3,312 |
|
|
| — |
|
Costs related to our exit of butter products |
|
| — |
|
|
| — |
|
|
| 7,764 |
|
|
| — |
|
Adjusted net (loss) income |
| $ | (6,460 | ) |
| $ | 16,419 |
|
| $ | (27,971 | ) |
| $ | 49,958 |
|
Weighted average common shares outstanding — basic |
|
| 42,931,849 |
|
|
| 44,721,206 |
|
|
| 42,730,366 |
|
|
| 44,521,146 |
|
Weighted average effect of potentially dilutive securities |
|
| — |
|
|
| 1,484,531 |
|
|
| — |
|
|
| 1,444,841 |
|
Weighted average common shares outstanding — diluted |
|
| 42,931,849 |
|
|
| 46,205,737 |
|
|
| 42,730,366 |
|
|
| 45,965,987 |
|
Adjusted net (loss) income per share: |
|
|
|
|
|
|
|
|
|
|
|
| ||||
Basic |
| $ | (0.15 | ) |
| $ | 0.37 |
|
| $ | (0.65 | ) |
| $ | 1.12 |
|
Diluted |
| $ | (0.15 | ) |
| $ | 0.36 |
|
| $ | (0.65 | ) |
| $ | 1.09 |
|
View source version on businesswire.com: https://www.businesswire.com/news/home/20261103981948/en/
Media:
Rob.Discher@vitalfarms.com
Investors:
Brian.Shipman@vitalfarms.com
Source: